Full-Time

Director Infusion Sales

BioPlus, West Coast

Updated on 9/10/2026

Deadline 9/14/26
Elevance Health

Elevance Health

10,001+ employees

Health benefits provider with digital platform

Compensation Overview

$148.9k - $255.3k/yr

+ Incentive bonus programs + Equity stock purchase

Company Historically Provides H1B Sponsorship

Las Vegas, NV, USA + 5 more

More locations: Seattle, WA, USA | Woodland Hills, Los Angeles, CA, USA | Walnut Creek, CA, USA | Denver, CO, USA | Costa Mesa, CA, USA

Hybrid

Field-based role with extensive travel and occasional office attendance; Elevance Health generally requires on-site work at least once per week unless designated primarily virtual.

Bachelor's

Category
Sales & Account Management (1)

Get referred to Elevance Health

See people who can refer or advise you

Requirements
  • A BA/BS and a minimum of 10 years of experience in the health insurance or related industry, or an equivalent combination of education and experience.
  • Minimum of 5 years of healthcare sales experience within home infusion, specialty pharmacy, specialty biologics, or infusion services, with demonstrated success driving referral growth, admissions, and revenue performance preferred.
  • Experience supporting neurology, immunology, intravenous immunoglobulin, subcutaneous immunoglobulin, biologics, blood products, enzyme replacement therapies, or other specialty infusion therapies preferred.
  • Experience selling into physician offices, specialty practices, infusion providers, ambulatory infusion centers, or alternate infusion care settings, with strong knowledge of specialty referral pathways and provider engagement strategies preferred.
  • Experience working for a manufacturer, specialty pharmacy, home infusion provider, or infusion services organization with responsibility for specialty market expansion, territory growth, and strategic account development preferred.
  • Strong business acumen with the ability to analyze referral trends, admissions, revenue mix, margin performance, and competitive market activity to drive strategic sales decisions and operational improvements preferred.
  • Excellent written, oral, presentation, interpersonal communication, and executive-level relationship-building skills, including the ability to influence stakeholders, lead cross-functional collaboration, and drive business growth initiatives preferred.
Responsibilities
  • Achieve or surpass business-unit revenue, referral-growth, admissions, margin, and profitability goals.
  • Produce sales results, provide strategic and operational direction, and develop trusting relationships with physician offices, specialty referral sources, and customers.
  • Manage and coach a field-based sales team to leverage relationships, drive referrals, expand new accounts, and support growth within targeted specialty markets including neurology and immunology.
  • Partner with key stakeholders on strategic planning, specialty growth initiatives, and implementation of operational process flows across infusion care settings.
  • Communicate information regarding competitors, market dynamics, referral trends, and issues affecting the business to leadership and the team.
  • Develop and execute sales meetings, field coaching, ride-alongs, and training initiatives to improve sales effectiveness and territory performance.
  • Collaborate with peers and cross-functional partners to continuously improve programs, sales execution, and customer experience.
  • Travel extensively throughout assigned regions to provide in-field leadership, coaching, and relationship-management support.
  • Hire, train, coach, counsel, and evaluate the performance of direct reports.

Elevance Health is a health benefits organization expanding into a lifetime trusted health partner. It serves more than 118 million people with about 100,000 associates and offers an integrated whole-health approach powered by a digital health platform, addressing a full range of needs across all stages of health. The product works by coordinating coverage, care, and wellness through its digital platform to deliver end-to-end support rather than standalone services. Compared with competitors, Elevance Health emphasizes a unified, end-to-end health experience at scale through its integrated platform and broad reach, aiming to connect members with a comprehensive set of health services. The company’s goal is to improve health for everyone by redefining health, reimagining the health system, and strengthening communities.

Company Size

10,001+

Company Stage

IPO

Headquarters

Indianapolis, Indiana

Founded

1944

Get referred to Elevance Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Second-quarter 2026 revenue reached $49.8 billion, and adjusted EPS guidance rose to $27.00.
  • Carelon revenue grew 6% in Q2 2026, driven by services and CarelonRx.
  • CMS closed the February 2026 risk-adjustment matter after Elevance paid $342 million.

What critics are saying

  • Elevance exited Washington, D.C. Medicaid on August 1, 2026, and targets more exits.
  • The CMS risk-adjustment probe cost $935 million in Q1 before the July closure.
  • The $14.75 million nurse overtime settlement signals broader wage-and-hour exposure across clinical operations.

What makes Elevance Health unique

  • Elevance’s 118 million-member scale powers pricing, data, and distribution advantages.
  • Carelon integrates pharmacy, behavioral health, and care management across health plans.
  • Management simplification in February 2026 centralized Carelon and Health Benefits decision-making.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, & vision insurance

401(k) + match

Paid holidays

Paid Time Off

Incentive bonus programs

Stock purchase plan

Life insurance

Wellness Programs

Financial education resources

Adoption & Surrogacy Assistance

Dependent-care Flexible Spending Account (DCFSA)

Parental Leave

Parental Transition Week

Critical Caregiving Leave

Company News

DistilInfo
Sep 3rd, 2026
Wellpoint taps Kraig Dalton as Tennessee COO.

Wellpoint taps Kraig Dalton as Tennessee COO. Kraig Dalton has joined Elevance Health's Wellpoint as COO of its Tennessee health plan, confirming the Kraig Dalton Wellpoint Tennessee COO appointment for this state-level insurance operation. Dalton's own words on this Wellpoint Tennessee COO appointment. "Supporting Tennesseans in need is deeply important to me, and I'm honored to take on this role leading operations at Wellpoint," Dalton said in an August LinkedIn post. This personal framing suggests Dalton views the role as an extension of a longstanding commitment to serving Tennessee's population specifically, rather than simply a lateral career move. Why this personal connection may matter for the role. Dalton's explicit emphasis on supporting Tennesseans, rather than a more generic statement about operational excellence, may reflect the direct, community-facing nature of leading operations for a state Medicaid-focused health plan, where outcomes are closely tied to the specific population the plan serves. Dalton's background before this Kraig Dalton Wellpoint Tennessee COO role. Dalton was most recently a director at Findhelp, a social care platform. According to Dalton's LinkedIn profile, he also has broader experience at Elevance Health, having previously directed Medicaid operations at Amerigroup in Tennessee and at UniCare, now Wellpoint, in West Virginia. Why this career path fits this appointment. Dalton's combination of prior Elevance Health Medicaid operations experience specifically in Tennessee, alongside his more recent work at a social care platform addressing social determinants of health, gives him a background spanning both the traditional managed care operations and the broader social needs infrastructure increasingly relevant to Medicaid-focused health plans. How this fits a broader wave of payer executive moves. This appointment adds to a cluster of payer leadership changes reported the same week, including UnitedHealthcare expanding Tom Kunst's role from CEO of Illinois commercial health plans to also oversee Michigan and Wisconsin, Johns Hopkins Health Plans naming an interim CEO, and UnitedHealthcare separately naming a CEO for its Washington state Medicaid plan. Why state-level Medicaid leadership carries added weight right now. This appointment also arrives as Tennessee's Medicaid managed care program navigates federal policy changes tied to HR 1, including new work requirements and more frequent eligibility checks phasing in for expansion populations. Given Dalton's direct prior experience overseeing Amerigroup's Tennessee Medicaid operations, his familiarity with the state's existing infrastructure and provider relationships may prove valuable as Wellpoint works to implement these federal changes smoothly, at a moment when several other states are already reporting early complications tied to similar eligibility verification rollouts. Why this clustering of state-level appointments matters. The concentration of multiple state-level health plan leadership appointments within the same short window, spanning UnitedHealthcare, Johns Hopkins Health Plans, and now Wellpoint, suggests insurers are actively investing in dedicated regional and state-specific leadership as they navigate an increasingly complex Medicaid and state-level regulatory environment. What this Kraig Dalton Wellpoint Tennessee COO appointment means going forward. With Dalton's direct prior experience in Tennessee Medicaid operations at Amerigroup, Wellpoint gains a COO with existing familiarity in the specific state market he'll now help lead, potentially easing his transition into this operational leadership role. Given his more recent background at Findhelp, Dalton's approach to Wellpoint's Tennessee operations may incorporate a stronger emphasis on connecting members to social care resources alongside traditional health plan administration. What to watch going forward. As Dalton settles into this role, industry observers will likely watch how his background bridging Medicaid operations and social care technology shapes Wellpoint's approach to serving Tennessee's Medicaid population. Given the broader wave of state-level payer executive appointments occurring across the industry this week, this Kraig Dalton Wellpoint Tennessee COO appointment may reflect a wider trend of insurers prioritizing leaders with direct, state-specific operational experience as they navigate increasingly localized Medicaid policy and program requirements.

Yahoo Finance
Sep 2nd, 2026
Elevance Health trails healthcare providers ETF despite 26.5% annual gain

Elevance Health, an Indianapolis-based health benefits company, has a market capitalisation of approximately $85.4 billion. The stock is down 7.6% from its 52-week high of $436.24, reached on 14 July. Over the past three months, Elevance Health shares gained marginally, underperforming the iShares US Healthcare Providers ETF, which rose 13.6%. Year-to-date, the stock is up 15%, whilst the ETF gained 19.8%. However, Elevance Health outperformed over the past year, climbing 26.5% compared to the broader healthcare sector's 21.6% return. The company's scale, consistent earnings growth, and strong capital allocation have supported this performance. Its earnings per share grew 7.2% annually over the past five years. Wall Street analysts have a "Moderate Buy" consensus rating, with a mean price target suggesting 10.6% upside potential.

Ticker Report
Aug 27th, 2026
Freestone Grove Partners LP Makes New $72.10 Million Investment in Elevance Health, Inc. $ELV

Freestone Grove Partners LP bought a new position in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 186,427 shares of the company’s stock, valued at approximately $72,097,000. Other large investors have also recently made […]

Yahoo Finance
Aug 26th, 2026
Elevance Health trades 11% below fair value as Carelon appoints new behavioral health leader

Elevance Health's Carelon Behavioral Health unit has appointed forensic psychiatrist Dr Patrick Fox as leader, overseeing behavioral services for more than 61 million members. The company's shares currently trade at $398.87, representing an 11% discount to the most followed fair value estimate of $449.10. Recent performance shows a 5.61% share price return over 30 days and 12.60% year-to-date. The one-year total shareholder return stands at 31.36%, contrasting with a 3-year decline of 8.49%. Analysts suggest strategic investments in digital consumer engagement and Carelon's diversified health services, including pharmacy, care management, and behavioral health, are accelerating revenue growth and providing higher-margin income streams. However, risks include potential Medicaid rate adjustments lagging rising medical costs and acquisition-related margin dilution.

DistilInfo
Aug 26th, 2026
Elevance Health settles nurse overtime lawsuits.

Elevance Health settles nurse overtime lawsuits. Table of contents. A federal judge has given final approval to a $14.75 million settlement between Elevance Health and a group of nurses who alleged the insurer misclassified them as exempt from overtime pay, closing out the Elevance Health nurse overtime settlement after years of consolidated litigation. How the Elevance Health nurse overtime settlement was approved. U.S. District Judge David Novak signed off on the deal Aug. 20 in the Eastern District of Virginia, closing out five related lawsuits that had been consolidated for settlement purposes. The cases were brought by nurses who worked in medical management and utilization review roles across Virginia, Minnesota, North Carolina and Maryland. The multi-state scope of this settlement. Consolidating lawsuits from nurses across four different states into a single settlement proceeding suggests the alleged misclassification practice was applied consistently across Elevance's operations in multiple regions, rather than being isolated to a single office or business unit. What the nurses alleged behind this Elevance Health nurse overtime settlement. In their complaints, some of which date back to 2022, the nurses alleged their primary job was reviewing medical authorization requests against pre-determined clinical guidelines and criteria, work they argued was non-exempt under the Fair Labor Standards Act and state overtime laws. The core comparison driving this claim. They pointed out that licensed practical nurses at Elevance performing the same type of reviews were classified as hourly and received overtime, while the salaried nurses routinely worked more than 40 hours a week without additional pay. This direct comparison between two groups of employees performing similar utilization review work under different pay classifications formed the central factual basis for the nurses' misclassification claims. The financial terms of this Elevance Health nurse overtime settlement. The court awarded roughly $4.92 million in attorneys' fees, representing one-third of the common fund, along with $240,000 in costs and $96,500 in service payments. This fee structure, allocating a third of the total settlement to attorneys' fees, is a common proportion in class and collective action wage-and-hour settlements of this size. What remains for the affected nurses. After deducting attorneys' fees, costs, and service payments from the $14.75 million common fund, the remaining balance will be distributed among the nurses who were part of the five consolidated lawsuits, compensating them for the overtime pay they argued they were denied under their exempt classification. How this fits a broader pattern of payer legal exposure. This settlement arrives amid a broader wave of legal and regulatory challenges facing Elevance Health and other major insurers, including a separate lawsuit filed the same week by a union health plan against OhioHealth and Cigna facing its own underpayment lawsuit from addiction treatment providers, reflecting an active period of litigation across the payer industry on multiple fronts simultaneously. Why wage classification disputes matter for insurers. Wage and hour misclassification disputes like this one carry particular relevance for insurers employing large clinical review workforces, since utilization review and medical management roles often sit at an ambiguous boundary between exempt professional judgment and non-exempt, criteria-based review work, a distinction this case specifically turned on. What this Elevance Health nurse overtime settlement means going forward. With final court approval now secured, Elevance Health can close out this multi-year, multi-state litigation, while the settlement itself may serve as a reference point for how courts evaluate similar exempt-status disputes involving utilization review nurses at other insurers. Given the specific comparison the nurses drew between their own salaried classification and LPNs' hourly classification for similar work, other insurers structuring their clinical review workforce may want to review how closely their own exempt-status determinations align with the actual day-to-day duties performed. What to watch going forward. As this settlement moves toward final distribution, industry observers will likely watch whether similar wage and hour claims emerge against other health insurers employing utilization review nurses under comparable exempt classifications. Given the broader pattern of legal challenges Elevance Health and other insurers are currently navigating, this Elevance Health nurse overtime settlement may prompt other payers to proactively review their own clinical staff classification practices to avoid similar litigation exposure going forward.